Cargando…

Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia

BACKGROUNDS: Autism is a family of developmental disorders of unknown origin. The disorder is characterized by behavioral, developmental, neuropathological and sensory abnormalities, and is usually diagnosed between the ages of 2 and 10 with peak prevalence rates observed in children aged 5-8 years....

Descripción completa

Detalles Bibliográficos
Autores principales: El-Ansary, Afaf K, Ben Bacha, Abir G, Al- Ayahdi, Layla Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107800/
https://www.ncbi.nlm.nih.gov/pubmed/21510882
http://dx.doi.org/10.1186/1476-511X-10-62
_version_ 1782205249661960192
author El-Ansary, Afaf K
Ben Bacha, Abir G
Al- Ayahdi, Layla Y
author_facet El-Ansary, Afaf K
Ben Bacha, Abir G
Al- Ayahdi, Layla Y
author_sort El-Ansary, Afaf K
collection PubMed
description BACKGROUNDS: Autism is a family of developmental disorders of unknown origin. The disorder is characterized by behavioral, developmental, neuropathological and sensory abnormalities, and is usually diagnosed between the ages of 2 and 10 with peak prevalence rates observed in children aged 5-8 years. Recently, there has been heightened interest in the role of plasma free fatty acids (FA) in the pathology of neurological disorders. The aim of this study is to compare plasma fatty acid profiles of Saudi autistic patients with those of age-matching control subjects in an attempt to clarify the role of FA in the etiology of autism. METHODS: 26 autistic patients together with 26-age-matching controls were enrolled in the present study. Methyl esters of FA were extracted with hexane, and the fatty acid composition of the extract was analyzed on a gas chromatography. RESULTS: The obtained data proved that fatty acids are altered in the plasma of autistic patients, specifically showing an increase in most of the saturated fatty acids except for propionic acid, and a decrease in most of polyunsaturated fatty acids. The altered fatty acid profile was discussed in relation to oxidative stress, mitochondrial dysfunction and the high lead (Pb) concentration previously reported in Saudi autistic patients. Statistical analysis of the obtained data shows that most of the measured fatty acids were significantly different in autistic patients compared to age -matching controls. CONCLUSIONS: Receiver Operating Characteristic (ROC) curve analysis shows satisfactory values of area under the curve (AUC) which could reflect the high degree of specificity and sensitivity of the altered fatty acids as biomarkers in autistic patients from Saudi Arabia.
format Online
Article
Text
id pubmed-3107800
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-31078002011-06-04 Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia El-Ansary, Afaf K Ben Bacha, Abir G Al- Ayahdi, Layla Y Lipids Health Dis Research BACKGROUNDS: Autism is a family of developmental disorders of unknown origin. The disorder is characterized by behavioral, developmental, neuropathological and sensory abnormalities, and is usually diagnosed between the ages of 2 and 10 with peak prevalence rates observed in children aged 5-8 years. Recently, there has been heightened interest in the role of plasma free fatty acids (FA) in the pathology of neurological disorders. The aim of this study is to compare plasma fatty acid profiles of Saudi autistic patients with those of age-matching control subjects in an attempt to clarify the role of FA in the etiology of autism. METHODS: 26 autistic patients together with 26-age-matching controls were enrolled in the present study. Methyl esters of FA were extracted with hexane, and the fatty acid composition of the extract was analyzed on a gas chromatography. RESULTS: The obtained data proved that fatty acids are altered in the plasma of autistic patients, specifically showing an increase in most of the saturated fatty acids except for propionic acid, and a decrease in most of polyunsaturated fatty acids. The altered fatty acid profile was discussed in relation to oxidative stress, mitochondrial dysfunction and the high lead (Pb) concentration previously reported in Saudi autistic patients. Statistical analysis of the obtained data shows that most of the measured fatty acids were significantly different in autistic patients compared to age -matching controls. CONCLUSIONS: Receiver Operating Characteristic (ROC) curve analysis shows satisfactory values of area under the curve (AUC) which could reflect the high degree of specificity and sensitivity of the altered fatty acids as biomarkers in autistic patients from Saudi Arabia. BioMed Central 2011-04-21 /pmc/articles/PMC3107800/ /pubmed/21510882 http://dx.doi.org/10.1186/1476-511X-10-62 Text en Copyright ©2011 El-Ansary et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
El-Ansary, Afaf K
Ben Bacha, Abir G
Al- Ayahdi, Layla Y
Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
title Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
title_full Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
title_fullStr Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
title_full_unstemmed Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
title_short Plasma fatty acids as diagnostic markers in autistic patients from Saudi Arabia
title_sort plasma fatty acids as diagnostic markers in autistic patients from saudi arabia
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3107800/
https://www.ncbi.nlm.nih.gov/pubmed/21510882
http://dx.doi.org/10.1186/1476-511X-10-62
work_keys_str_mv AT elansaryafafk plasmafattyacidsasdiagnosticmarkersinautisticpatientsfromsaudiarabia
AT benbachaabirg plasmafattyacidsasdiagnosticmarkersinautisticpatientsfromsaudiarabia
AT alayahdilaylay plasmafattyacidsasdiagnosticmarkersinautisticpatientsfromsaudiarabia